Compare Amgen, Inc. (AMGN) vs Innovative Industrial Properties Inc (IIPR) Price & Performance

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

IIPR trades at $64.44, up 2.16% with a bullish technical signal from moving averages. The REIT shows strong profitability with 45.58% net margins and stable quarterly earnings beats. Recent developments include successful debt refinancing and a $1.90 quarterly dividend declaration. Valuation appears reasonable with P/E of 16.44 and P/B of 1.05, though revenue declined to $266M in 2025.

Outlook remains positive with cannabis rescheduling progress and improved capital structure, but risks include tenant credit quality and sector volatility. The 13.32% dividend yield offers income appeal, though coverage requires monitoring. Analyst consensus leans cautious with 36% buy ratings amid revenue pressure.